Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-28

FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for doxazosin from Mylan Pharmaceuticals Inc., signaling a regulatory action that likely updates labeling or related pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

SUPPL AP for DOXAZOSIN (DOXAZOSIN)